Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Fesco to launch direct transportation between Russia and Tanzania

10/29/24 FESH

Fesco increased transportation between Vladivostok and China

10/29/24 FESH

Lenta reported for 9 months of 2024 by RAS

10/29/24 LENT

Lambumize IPO went under the bottom line

10/29/24 LMBZ

Lenzoloto reported for 9 months of 2024 by RAS

10/29/24 LNZL

Bashinformsvyaz reported for 9 months of 2024 by RAS

10/29/24 BISVP

VTB reports for 9 months of 2024 by RAS

10/29/24 VTBR

Gazprom reported for 9 months of 2024 by RAS

10/29/24 GAZP

IK RUSS-INVEST reported for 9 months of 2024 by RAS

10/29/24 RUSI

DIOD reported for 9 months of 2024 by RAS

10/29/24 DIOD